Complementary medicine use among women enrolled in a genetic testing program

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 4, 2003, Pages 321-326

  DiGianni, Lisa M ^a   Kim, Haesook T ^a   Emmons, Karen ^a   Gelman, Rebecca ^a   Kalkbrenner, Kathy J ^a   Garber, Judy E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; HERBACEOUS AGENT; VITAMIN;

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; DEPRESSION; FEMALE; FRUIT; GENETIC ANALYSIS; HEALTH BEHAVIOR; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MASSAGE; ONCOGENE; OVARY CANCER; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; VEGETABLE;

ADOLESCENT; ADULT; BREAST NEOPLASMS; COHORT STUDIES; COMPLEMENTARY THERAPIES; DEPRESSION; EDUCATIONAL STATUS; FEMALE; GENETIC SCREENING; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RISK MANAGEMENT; STATISTICS; SURVIVORS; WOMEN'S HEALTH;

EID: 0037388358     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Eisenberg, D., Davis, R., Ettner, S., Appel, S., Wilkey, S., Van Rompay, M., and Kessler, R. C. Trends in alternative medicine use in the United States, 1990-1997. JAMA, 280: 1569-1575, 1998.
2. National Center for Complementary and Alternative Medicine, Department of Health and Human Services, and National Institues of Health Expanding Horizons of Healthcare: Five-Year Strategic Plan 2001-2005, 2000.
3. Crocetti, E., Crotti, N., Feltrin, A., Ponton, P., Geddes, M., and Buiatti, E. The use of complementary therapies by breast cancer patients attending conventional treatment. Eur. J. Cancer, 34: 324-328, 1998.
4. Boon, H., Stewart, M., Kennard, M. A., Gray, R., Sawka, C., Brown, J., McWilliam, C., Gavin, A., Baron, R., Aaron, D., and Haines-Kamka, T. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J. Clin. Oncol., 18: 2515-2521, 2000.
5. Eisenberg, D., Kessler, R., Foster, C., and Kronenberg, F. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N. Eng. J. Med., 328: 246-252, 1993.
6. Kaptchuk, T. J., and Eisenberg, D. M. The persuasive appeal of alternative medicine. Ann. Intern. Med., 129: 1061-1065, 1998.
7. Eisenberg, D., Kessler, R., Van Rompay, M., Kaptchuk, T., Wilkey, S., Appel, S., and Davis, R. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann. Intern. Med., 135: 344-351, 2001.
8. Kessler, R., Soukup, J., Davis, R., Foster, D., Wilkey, S., Van Rompay, M., and Eisenberg, D. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am. J. Psychiatry, 158: 289-294, 2001.
9. Sparber, A., Bauer, L., Curt, G., Eisenberg, D., Levin, T., Parks, S., Steinberg, S. M., and Wootton, J. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncology Nursing Forum, 27: 623-630, 2000.
10. Richardson, M. A., Sanders, T., Palmer, J. L., Greisinger, A., and Singletary, S. E. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J. Clin. Oncol., 18: 2505-2514, 2000.
11. Morris, K., Johnson, N., Homer, L., and Walts, D. A Comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am. J. Surg., 179: 407-411, 2000.
12. Redd, W., Montgomery, G., and DuHamel, K. Behavioral intervention for cancer treatment side effects. J. Natl. Cancer Inst. (Bethesda), 93: 810-823, 2001.
13. Persky, V., and Van Horn, L. Epidemiology of soy and cancer: perspectives and directions. J. Nutr., 125: 709S-712S, 1995.
14. Bridge, L., and Benson, P. Relaxation and imagery in the treatment of breast cancer. Br. Med. J., 297: 1169-1172, 1988.
15. Lekander, M., Furst, C., Rotstein, S., Hursti, T., and Fredrikson, M. Immune Effects of relaxation during chemotherapy for ovarian cancer. Psychotherapy and Psychosomatics, 66: 185-191, 1997.
16. Jacobson, J. S., Workman, S. B., and Kronenberg, F. Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. J. Clin. Oncol., 18: 668-683, 2000.
17. Burstein, H. J., Gelber, S., Guadagnol, E., and Weeks, J. Use of alternative medicine by women with early-stage breast cancer. N. Eng. J. Med., 340: 1733-1739, 1999.
18. Lerman, C., Hughes, C., Croyle, R., Main, D., Durham, C., Snyder, C., Bonney, A., Lynch, J., Narod, S., and Lynch, H. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev. Med., 31: 75-80, 2000.
19. Brain, K., Gray, J., Norman, P., Parsons, E., Clarke, A., Rogers, C., Mansel, R., and Harper, P. Why do women attend familial breast cancer clinics? J. Med. Genet., 37: 197-202, 1999.
20. Bluman, L., Borstelmann, N., Rimer, B., Iglehart, J., and Winer, E. Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. Journal of Women's Health and Gender-Based Medicine, 10: 589-598, 2001.
21. Emmons, K., Marcus, B., and Linnan, L. Mechanisms in multiple risk factor interventions: smoking, physical activity, and dietary fat intake among manufacturing workers. Prev. Med., 23: 481-489, 1994.
22. Smith-Warner, S., Spiegelman, D., Adami, H., Beeson, W., vanden Brandt, P., Folsom, A., Fraser, G., Freudenheim, J., Goldbohm, R., Graham, S., Kushi, L., Miller, A., Roham, T., Speizer, F., Toniolo, P., Willett, W., Wolk, A., Zeleniuch-Jacquotte, A., and Hunter, D. Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int. J. Cancer, 92: 767-774, 2001.
23. Willett, W. Diet and cancer: one view at the start of the millennium. Cancer Epidemiol. Biomark. Prev., 10: 3-8, 2001.
24. Subar, A., Heimendinger, J., Krebs-Smith, S., Patterson, B., Kessler, R., and Pivonka, E. (eds.). Five a Day for Better Health: A Baseline Study of Americans' Fruit and Vegetable Consumption. Bethesda, MD: National Cancer Institute, 1992.
25. Becker, M., Drachman, R., and Kirscht, J. A new approach to explaining sick-role behavior in low-income populations. Am. J. Public Health, 64: 205-216, 1974.
26. Meiser, B., Butow, P., Barratt, A., Schnieden, V., Gattas, M., Kirk, J., Suthers, G., and Tucker, K. Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Education and Counseling, 44: 215-225, 2001.
27. Derogatis, L., and Spencer, P. (eds.). Brief Symptom Inventory (BSI): Administration, Scoring, and Procedures Manual. Baltimore: Clinical Psychometric Research., 1992.
28. SAS Institute SAS/STAT User's Guide, Version 6. Cary, NC, 1990.
29. U. S. Department of Health and Human Services, Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. and Office on Smoking and Health Women and Smoking: A Report of the Surgeon General, 2001.
30. U. S. Department of Health and Human Services and Centers for Disease Control and Prevention Skin Cancer: Preventing America's Most Common Cancer, 2001.
31. Emmons, K., Kalkbrenner, K., Klar, N., Light, T., Schneider, K., and Garber, I. Behavioral risk factors among women presenting for genetic testing. Cancer Epidemiol. Biomark. Prev., 9: 89-93, 2000.
32. Kessler, R., Davis, R., Foster, D., Van Rompay, M., Walters, E., Wilkey, S., Kaptchuk, T. J., and Eisenberg, D. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann. Intern. Med., 135: 262-268, 2001.
33. Bluman, L., Rimer, B., Berry, D., Borstelmann, N., Iglehart, J., Regan, K., Schildkraut, J., and Winer, E. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J. Clin. Oncol., 17: 1040-1046, 1999.
34. Kash, K., Holland, J., Halper, M., and Miller, D. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J. Natl. Cancer Inst. (Bethesda), 1: 24-30, 1992.
35. Kash, K., Holland, J., Osborne, M., and Miller, D. Psychological counseling strategies for women at risk of breast cancer. J. Natl. Cancer Inst. Monogr., 17: 73-79, 1995.
36. Ganz, P., Desmond, K., Leedham, B., Rowland, J., Meyerowitz, B., and Belin, T. Quality of life in long-term, disease-free suvivors of breast cancer: a follow-up study. J. Natl. Cancer Inst. (Bethesda), 94: 39-49, 2002.
37. Edgar, L., Remmer, J., Rosberger, Z., and Fournier, M. Resource use in women completing treatment for breast cancer. Psychooncology, 9: 428-438, 2000.
38. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., and Lynch, H. BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA, 275: 1885-1892, 1996.